Tae Hwan Shin1, Hyoun-Ah Kim2, Ju-Yang Jung2, Wook-Young Baek2, Hyeon-Seong Lee1,3, Hyung Jin Park1, Jeuk Min3, Man-Jeong Paik3, Gwang Lee4, Chang-Hee Suh5. 1. Department of Physiology, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea. 2. Department of Rheumatology and BK21 Division of Cell Transformation and Restoration, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea. 3. College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea. 4. Department of Physiology, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea. glee@ajou.ac.kr. 5. Department of Rheumatology and BK21 Division of Cell Transformation and Restoration, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea. chsuh@ajou.ac.kr.
Abstract
INTRODUCTION: Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with heterogeneous clinical manifestations mediated by immune dysregulation. OBJECTIVES: We aimed to analyze the metabolomic differences in free fatty acids (FFAs) between patients with SLE and healthy controls (HCs). METHODS: In this study, the levels of 24 FFAs, as their tert-butyldimethylsilyl derivatives, in the plasma of 41 patients with SLE and 41 HCs, were investigated using gas chromatography with mass spectrometry in selected-ion monitoring mode. RESULTS: The results showed that patients with SLE and HCs had significantly different levels of 13 of the 24 FFAs. The levels of myristic, palmitoleic, oleic, and eicosenoic acids were significantly higher, whereas the levels of caproic, caprylic, linoleic, stearic, arachidonic, eicosanoic, behenic, lignoceric, and hexacosanoic acids were significantly lower in patients with SLE, than in the HCs. In the partial-correlation analysis of the FFA profiles and markers of disease activity of SLE, several metabolic markers correlated with SLE disease activity. CONCLUSIONS: Our results provide a comprehensive understanding of the relationship between FFAs and markers of SLE disease activity. Thus, this approach has promising potential for the discovery of metabolic biomarkers of SLE.
INTRODUCTION:Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with heterogeneous clinical manifestations mediated by immune dysregulation. OBJECTIVES: We aimed to analyze the metabolomic differences in free fatty acids (FFAs) between patients with SLE and healthy controls (HCs). METHODS: In this study, the levels of 24 FFAs, as their tert-butyldimethylsilyl derivatives, in the plasma of 41 patients with SLE and 41 HCs, were investigated using gas chromatography with mass spectrometry in selected-ion monitoring mode. RESULTS: The results showed that patients with SLE and HCs had significantly different levels of 13 of the 24 FFAs. The levels of myristic, palmitoleic, oleic, and eicosenoic acids were significantly higher, whereas the levels of caproic, caprylic, linoleic, stearic, arachidonic, eicosanoic, behenic, lignoceric, and hexacosanoic acids were significantly lower in patients with SLE, than in the HCs. In the partial-correlation analysis of the FFA profiles and markers of disease activity of SLE, several metabolic markers correlated with SLE disease activity. CONCLUSIONS: Our results provide a comprehensive understanding of the relationship between FFAs and markers of SLE disease activity. Thus, this approach has promising potential for the discovery of metabolic biomarkers of SLE.
Authors: Man Jeong Paik; Ki Ho Park; Joong Jean Park; Kyoung Rae Kim; Young Hwan Ahn; Gyu Tae Shin; Gwang Lee Journal: J Biochem Mol Biol Date: 2007-01-31
Authors: E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester Journal: Arthritis Rheum Date: 1982-11
Authors: M J Ormseth; L L Swift; S Fazio; M F Linton; P Raggi; J F Solus; A Oeser; A Bian; T Gebretsadik; A Shintani; C M Stein Journal: Lupus Date: 2012-10-11 Impact factor: 2.911
Authors: Camila O Souza; Alexandre A S Teixeira; Edson A Lima; Helena A P Batatinha; Lara M Gomes; Milena Carvalho-Silva; Isabella T Mota; Emilio L Streck; Sandro M Hirabara; José C Rosa Neto Journal: Mediators Inflamm Date: 2014-07-24 Impact factor: 4.711
Authors: Yana Zhang; Ming Gui; Yajun Wang; Nikita Mani; Shuvam Chaudhuri; Beixue Gao; Huabin Li; Yashpal S Kanwar; Sarah A Lewis; Sabrina N Dumas; James M Ntambi; Kezhong Zhang; Deyu Fang Journal: Arthritis Rheumatol Date: 2021-11-02 Impact factor: 10.995